Sign In
Buy HTBX
$2.38
+0 (+0%)
At Close: Aug 17, 2022
Immutep publishes interim results for two ongoing studies, scoops $3.6 million in R&D grant
01:19am, Monday, 01'st Jun 2020
Biotechnology company Immutep (ASX: IMM) has published results from two ongoing clinical studies, just days after revealing it received €2.1 million (A$3.6 million) in research and development tax i
Biomarck Pharmaceuticals, Ltd., a biopharmaceutical company developing targeted anti-MARCKS technology for the treatment of ARDS [Acute Respiratory Di
ASCO data back AZ/Daiichi Sankyo’s Enhertu in new HER2 cancers -
01:52pm, Saturday, 30'th May 2020
A trifecta of phase 2 trial results in lung, stomach and colorectal cancer bode well for the blockbuster sales projections for AstraZeneca and Daiichi Sankyo HER2 antibody-drug conjugate Enhertu
Chi-Med to Discuss Select Global Clinical Trial Data Presented at ASCO20 | MarketScreener
12:02pm, Friday, 29'th May 2020
DURHAM, NC / ACCESSWIRE / May 29, 2020 / Heat Biologics, Inc. ("Heat") (HTBX), a clinical-stage biopharmaceutical company focused on developing first-in-class therapies to modulate the immune system,
The
ER doctor: 12-18 month coronavirus vaccine timeline 'is extremely optimistic'
03:34pm, Thursday, 28'th May 2020
As the fallout from the coronavirus pandemic continues, the search for a vaccine is not slowing down.
BMS wins another lung cancer approval for its Opdivo+Yervoy combo -
06:57am, Thursday, 28'th May 2020
Bristol-Myers Squibb has won a second first-line lung cancer approval from the FDA for its Opdivo and Yervoy combination.
Xconomy: Gilead Gains Foothold in Solid Tumors With $375M, 10-Year Arcus Bio Pact
08:36pm, Wednesday, 27'th May 2020
With the year’s biggest oncology conference days away, Gilead Sciences is signaling now what its cancer immunotherapy pipeline could look like in the
Heat Biologics Announces Collaboration With Waisman Biomanufacturing To Manufacture COVID-19 Coronavirus Vaccine
12:02pm, Wednesday, 27'th May 2020Heat Biologics Announces Collaboration with Waisman Biomanufacturing to Manufacture COVID-19 Vaccine
12:00pm, Wednesday, 27'th May 2020
DURHAM, NC / ACCESSWIRE / May 27, 2020 / Heat Biologics, Inc. ("Heat") (HTBX), a clinical-stage biopharmaceutical company specialized in the development of novel therapeutic and prophylactic vaccines,
